Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,389 public trials 159 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

American Ginseng Extract in Preventing Respiratory Infection and in Reducing Antibiotic Use in Patients With CLL

NCT00752895

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Providence Saint Joseph Medical Center - Burbank Burbank, California, United States
  • St. Joseph Hospital Regional Cancer Center - Orange Orange, California, United States
  • Helen and Harry Gray Cancer Center at Hartford Hospital Hartford, Connecticut, United States
  • Saint Anthony's Hospital at Saint Anthony's Health Center Alton, Illinois, United States
View all 125 locations
View Trial Details
Completed

A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT02406742

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • University of California San Diego La Jolla, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Weill Cornell Medical College Dr. Feldman's Office New York, United States
View all 24 locations
View Trial Details
Completed

Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient Program

NCT02582320

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • U.O.C. Ematologia e Terapia Cellulare - Ospedale "C. e G. Mazzoni" di Ascoli Piceno Ascoli Piceno, Italy
  • U.O.C di Ematologia P.O. "S.Giuseppe Moscati" - 2° piano Aversa, Italy
  • UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro Bari, Italy
  • Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy
View all 47 locations
View Trial Details
Completed

Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT01767766

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +22 more
Locations
  • TG Therapeutics Trial Site Sarasota, Florida, United States
  • TG Therapeutics Trial Site Hackensack, New Jersey, United States
  • TG Therapeutics Trial Site New York, United States
  • TG Therapeutics Trial Site Durham, North Carolina, United States
View Trial Details
Completed

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

NCT00546793

Conditions
CLL, Chronic Disease, Dendritic Cell Sarcoma, Interdigitating, +35 more
Locations
  • Lewis Cancer Center and Research Pavilion Savannah, Georgia, United States
  • Cancer Care at Saint Clare's/Saint Clares Hospital Oncology & Hematology Specialists, P.A. Denville, New Jersey, United States
  • Morristown Memorial Hospital Morristown, New Jersey, United States
  • New York Hospital Weill Cornell Medical Center New York, United States
View Trial Details
Completed

Study Evaluating Venetoclax in Subjects With Hematological Malignancies

NCT02265731

Conditions
Acute Myeloid Leukemia (AML), Blood Protein Disorders, Cardiovascular Diseases, +30 more
Locations
  • NHO Nagoya Medical Center /ID# 129222 Nagoya, Aichi-ken, Japan
  • Aichi Cancer Center Hospital /ID# 129061 Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital /ID# 129278 Nagoya, Aichi-ken, Japan
  • University of Fukui Hospital /ID# 165801 Yoshida-gun, Fukui, Japan
View all 14 locations
View Trial Details

Related conditions